Riccardo Panella
Technik-/Wissenschafts-/F&E-Leiter bei Resalis Therapeutics SRL
Ursprung des Netzwerks ersten Grades von Riccardo Panella
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Resalis Therapeutics SRL
Resalis Therapeutics SRL Miscellaneous Commercial ServicesCommercial Services Resalis Therapeutics SRL is a company that focuses on developing a transformative metabolic disease approach to target obesity and fatty liver disease. The company is based in Turin, Italy. The Italian company's lead program, RES-010, is a safe and convenient treatment that provides disease-modifying therapeutic impact, including durable weight loss and reduction of hepatic steatosis. The CEO of the company is Eva Castagnetti.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Riccardo Panella
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Claris Ventures Sgr SpA
Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy. | Investment Managers | Founder Private Equity Investor | |
Innogest SGR SpA
Innogest SGR SpA Investment ManagersFinance Innogest SGR SpA (Innogest) is a private equity firm founded in 2005 by Claudio Giuliano and Marco Pinciroli. The firm is headquartered in Milan, Italy. | Investment Managers | Private Equity Analyst | |
St. Thomas Hospital, Inc.
St. Thomas Hospital, Inc. Hospital/Nursing ManagementHealth Services St. Thomas Hospital, Inc. operates hospitals. The private company is based in St. Thomas, VI. and has subsidiaries in United States. | Hospital/Nursing Management | Corporate Officer/Principal | |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Kent County Memorial Hospital
Kent County Memorial Hospital Hospital/Nursing ManagementHealth Services Kent County Memorial Hospital provides health care services. It also provides inpatient services including cardiology and extended coronary care, infectious disease, primary care, oncology, orthopedics, obstetrics and gynecology, pediatrics, rehabilitation and surgery. The company was founded in 1951 and is headquartered in Warwick, RI. | Hospital/Nursing Management | Corporate Officer/Principal | |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The King's College (New York) | College/University | Undergraduate Degree | |
University of London | College/University | Doctorate Degree | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
EFFECTOR THERAPEUTICS, INC. | Biotechnology | Consultant / Advisor | |
ARCTURUS THERAPEUTICS HOLDINGS INC. | Pharmaceuticals: Major | Consultant / Advisor | |
US Air Force | Sovereign | Consultant / Advisor | |
East Carolina University | College/University | Graduate Degree | |
Brody School of Medicine | College/University | Doctorate Degree | |
Wright State University (Ohio) | College/University | Graduate Degree | |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
Italian Angels for Growth
Italian Angels for Growth Investment ManagersFinance Italian Angels for Growth (IAG)is an venture capital firm founded in 2007 by Andrea Mandel Mantello, Antonio Sfiligoj, Enrico Castellano, Francesco Marini Clarelli, Lorenzo Franchini, Luigi Amati, Luigi Capello, Marco Asquini and Marco Villa. The firm is headquartered in Milan, Italy. | Investment Managers | Private Equity Investor | |
Kontron Instruments SpA | Chief Executive Officer | ||
CellPly SRL
CellPly SRL Medical SpecialtiesHealth Technology CellPly SRL develops and markets customized diagnostic tools for cancer treatment. The firm specializes in the design and marketing of solutions for defining the efficacy of immunotherapies and chemotherapies on cancer and immune cells. It offers a platform that analyzes ex-vivo samples and rare cells immediately after obtaining them from patients and preserving microenvironment conditions to readily provide information about tumor cell sensitivity to drugs and in-vivo status of single immune cells located close to tumor cells. The firm focuses on helping oncologists selecting the best treatment options, scientists studying cell response to therapy, and pharmaceutical companies increasing drug efficacy and rescuing drugs with limited efficacy through patient stratification. The company was founded by Massimo Bocchi and Roberto Guerrieri in 2013 and is headquartered in Bologna, Italy. | Medical Specialties | Director/Board Member | |
Olympus Group, Inc.
Olympus Group, Inc. Engineering & ConstructionIndustrial Services Olympus Group, Inc. provides civil engineering services. It services include civil engineering, which include multi-family podium, commercial, retail and industrial, single and multi family residential, earthworks, infrastructure studies and sewer capacity analysis and planning, surveying and specialty services. The company was founded on October 16, 2009 and is headquartered in Orangevale, CA. | Engineering & Construction | Corporate Officer/Principal | |
Bellco SRL
Bellco SRL Medical SpecialtiesHealth Technology Bellco SRL provides therapies and systems for the treatment of renal failure, multiple organ failure, sepsis and congestive heart failure. It offers haemodiafiltration therapies, dialysis machines equipment, haemodialysers, blood lines, catheters, concentrates, and sorbent cartridges; pathologies for acute patients; and altered haemodynamics, renal hypoperfusion, and low cardiac output therapeutic system for neonatal patients. The company was founded in 1972 and is headquartered in Mirandola, Italy.^ | Medical Specialties | Chairman | |
Repron Therapeutics Srl
Repron Therapeutics Srl Internet Software/ServicesTechnology Services Repron Therapeutics Srl is an Italian company that operates as an epigenetic silencing platform for tumor recurrence repression. The company is based in Milan, Italy. The company was founded by Alessandro Sessa and Vania Broccoli. | Internet Software/Services | Director/Board Member | |
Politecnico di Torino | College/University | Undergraduate Degree | |
College des Ingenieurs | College/University | Masters Business Admin | |
Magneti Marelli After Market Parts & Services SpA
Magneti Marelli After Market Parts & Services SpA Wholesale DistributorsDistribution Services Magneti Marelli After Market Parts & Services SpA sells and distributes automotive spare parts and components. The firm offers parts for maintenance, repair, and collision. It also provides related services such as training, fleet and insurance management, and tutorship. The company is headquartered in Milan, Italy. | Wholesale Distributors | Corporate Officer/Principal | |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Heqet Therapeutics SRL
Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Heqet Therapeutics SRL is an Italian biotechnology company that specializes in cardiac regenerative medicine. The company is based in Turin, Italy. The company was founded by Mauro Giacca. Marta Antonucci has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Vereinigte Staaten | 15 |
Italien | 12 |
Vereinigtes Königreich | 4 |
Dänemark | 2 |
Frankreich | 2 |
Sektoral
Health Technology | 12 |
Consumer Services | 8 |
Finance | 5 |
Health Services | 3 |
Distribution Services | 3 |
Operativ
Director/Board Member | 10 |
Corporate Officer/Principal | 6 |
Private Equity Investor | 4 |
Undergraduate Degree | 4 |
Consultant / Advisor | 4 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Michael Hodges | 20 |
Pietro Puglisi | 9 |
Antonio Leone | 7 |
Mike Hodges | 1 |
- Börse
- Insiders
- Riccardo Panella
- Unternehmensverbindungen